Lord Beaverbrook Chairman
I am pleased to welcome you to the Thorn Medical Plc website.
As a result of a recent in depth review, the Board has decided that the Company will now focus its resources on the fast-growing personalised medicine sector, specifically the provision of human cell therapies.
Thorn Medical plc will retain and invest in the core competencies that support this strategy. The Company will look to divest itself of its non-core assets. To support this, the Company will seek out collaborations, partnerships and acquisitions to support & enhance its position as a leading provider of cell therapies.
Our goal is to retain our core Intellectual Property (IP) within the Company and drive Shareholder value. The Company has much potential and the developments outlined above will drive the mission and focus of the group.
This year will be an exciting period for the Company and we look forward to keeping you updated as we progress.